Optimizing Axillary Management in Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy is a research paper published in Clinical Breast Cancer (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Harvard Catalyst
National Center for Advancing Translational Sciences
National Institutes of Health
Harvard University
MeSH Terms
Keywords